Open AccessA multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia
Author(s) -
Demet Çekdemir,
Serkan Güvenç,
Füsun Özdemirkıran,
Ali Eser,
Tayfur Toptaş,
Vildan Özkocaman,
Handan Haydaroğlu Şahin,
Esra Ermiş Turak,
Ramazan Esen,
Melda Cömert,
Sevil Sadri,
M. Aslaner,
Bahar Uncu Ulu,
Abdullah Karakuş,
Derya Selim Bapur,
İnci Alacacıoğlu,
Demet Aydın,
Atakan Tekinalp,
Sinem Namdaroğlu,
Funda Ceran,
Pınar Tarkun,
Demet Kiper,
Mustafa Çetiner,
Mustafa Nuri Yenerel,
Ahmet Muzaffer Demir,
Güven Yılmaz,
Hatice Terzi,
Erden Atilla,
Ümi̇t Yavuz Malkan,
Kadir Acar,
Erman Öztürk,
Anıl Tombak,
Cenk Sunu,
Ozan Salim,
Nevin Alayvaz,
Özkan Sayan,
Ülkü Özan,
Mesut Ayer,
Zafer Gökgöz,
Neslihan Andıç,
Ebru Kızılkılıç,
Figen Noyan,
Mehmet Ali Özen,
Funda Pepedil Tanrıkulu,
Güçhan Alanoğlu,
Hasan Özkan,
Vahap Aslan,
Güven Çetin,
Alev Akyol Erikçi,
Burak Devecı,
Fadime Ersoy Dursun,
Hasan Dermenci,
Pelin Aytan,
Mehmet Gündüz,
Volkan Karakuş,
Can Özlü,
Si̇nan Demi̇rci̇oğlu,
Olga Meltem Akay Yanar,
Düzgün Özatlı,
Levent Ündar,
Eyüp Naci Tiftik,
Ayhan Sucak,
İbrahim C. Haznedaroğlu,
Muhıt Özcan,
Mehmet Şencan,
Murat Tombuloğlu,
Gülsüm Özet,
Oktay Bilgir,
Burhan Turgut,
Mehmet Ali Özcan,
Kadriye Bahriye Payzın,
Mehmet Sönmez,
Orhan Ayyıldız,
Mehmet Sinan Dal,
Şehmus Ertop,
Mehmet Turğut,
Teoman Soysal,
Emin Kaya,
Ali Ünal,
Mustafa Pehlıvan,
Işık Kaygusuz Atagündüz,
T Firatli,
Güray Saydam,
Reyhan Diz Küçükkaya
Publication year - 2019
Publication title -
turkish journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.351
H-Index - 16
ISSN - 1300-7777
DOI - 10.4274/tjh.galenos.2019.2018.0307
Subject(s) - eltrombopag , medicine , platelet , refractory (planetary science) , immune thrombocytopenia , thrombopoietin receptor , gastroenterology , complete blood count , retrospective cohort study , cohort , complete response , thrombopoietin , chemotherapy , haematopoiesis , physics , genetics , stem cell , astrobiology , biology
The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).